Skip to main content
Premium Trial:

Request an Annual Quote

Nanopoint, Invitrogen, Lab Armor

Nanopoint recently announced that this month it will formally launch its cellTRAY imaging system model CT-2000 and make its cellTRAY fluidics system model CT-2000F commercially available for purchase.
Nanopoint's cellTRAY imaging system Model CT-2000 adds in navigation and image-acquisition capabilities for drug screening and targeted nanoparticle delivery applications, the company said. The CT-2000 system allows experiments to run on an inverted microscope for extended periods of time, enabling time-lapse imaging of live cells over the course of several days.

Invitrogen now offers GIBCO Collagen I, Rat Tail to customers for their 3D cell culture needs, the company announced recently.
According to the manufacturer, GIBCO Collagen I is of high quality and forms a clearer, firmer gel than other commercially available collagen products. The product includes protocols for each application.

Lab Armor this week announced the availability of Bath Armor, a dry, autoclavable highly-conductive thermal media designed for use in heat blocks and to replace the water in laboratory water baths.
Bath Armor is made of a moisture- and gas-impermeable aluminum composite.

According to the manufacturer, Bath Armor dry media protects laboratory samples and personnel against contamination and reduces laboratory maintenance and equipment costs.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.